Home6185 • HKG
add
Cansino Biologics Inc
Previous close
$33.25
Day range
$32.30 - $33.25
Year range
$16.34 - $42.20
Market cap
11.51B HKD
Avg Volume
1.44M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 137.16M | 20.02% |
Operating expense | 131.82M | -27.18% |
Net income | -11.55M | 93.21% |
Net profit margin | -8.42 | 94.34% |
Earnings per share | — | — |
EBITDA | 27.96M | 152.87% |
Effective tax rate | 30.43% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.09B | -23.08% |
Total assets | 7.82B | -8.73% |
Total liabilities | 2.92B | -15.61% |
Total equity | 4.90B | — |
Shares outstanding | 230.91M | — |
Price to book | 1.57 | — |
Return on assets | -0.58% | — |
Return on capital | -0.70% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -11.55M | 93.21% |
Cash from operations | -13.80M | 87.24% |
Cash from investing | -437.36M | -259.03% |
Cash from financing | -46.37M | -131.46% |
Net change in cash | -500.14M | -252.11% |
Free cash flow | 505.08M | 211.21% |
About
CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia
CEO
Founded
Jan 13, 2009
Website
Employees
1,105
